CSIMarket
 




Respirerx Pharmaceuticals Inc   (RSPI)
Other Ticker:  
 
 



RSPI Price to Earnings Ratio (Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Diluted EPS 12 Trailing Months II. Quarter I. Quarter IV. Quarter III. Quarter II. Quarter
PE (TTM) Ratio current            -            -            -            -            -
Diluted EPS TTM Y / Y Change -25.99 % -10.25 % -10.25 % -35.19 % -35.19 %
Diluted EPS Y / Y Change -60 % -0 % -48.03 % -0 % -0 %
Stock performance to date -62.96 % -29.27 % -30 % 35.71 % -41.43 %

Price to earnings ratio Comment
Respirerx Pharmaceuticals Inc 's recorded net loss in trailing twelve months.

Within Healthcare sector Respirerx Pharmaceuticals Inc has the lowest Price to earnings ratio.

What is Price to Earnings Ratio?
What is Respirerx Pharmaceuticals Inc Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #0
Sector #0
S&P 500 #1







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com